Viropro, a stock traded on the US Over The Counter Bulletin Board. It focuses on process development and cGMP manufacturing services through its subsidiaries Viropro International Inc. (Montreal), Biologics Process Development
(California) and Alpha Biologics Sdn Bhd (Penang and UK).
SBV’s original investee company, Alpha Biologics, was sold to Viropro and in return, Viropro shares were issued to SBV.
There were changes to the management of Viropro in 2012. It is currently led by Cynthia Ekberg Tsai, the Chairman of Viropro. She has expertise in private equity financing and development of high-growth healthcare companies.